Dr Martin Hogg qualified from Oxford University in 1990 having developed a particular interest in Oncology during his time there. In additional to his medical studies, he took a degree in physiological sciences specialising in cellular physiology, biology and immunology as well as undertaking some undergraduate research work developing a novel technique for assessing reflux of ions across cell membranes. He continued his medical studies at St Bartholomew’s Medical School in London qualifying in 1993 as a doctor from the University of London. Continuing the Oncological vein his first house job was in leukaemia and lymphoma working under Professor Rohitiner and Professor Lister at Barts. Following the normal general medical training as a Senior House Officer in the Leicestershire rotation he moved to the Christie Hospital as a Specialist Registrar in Oncology. He was along with Dr B Yapp the first to start on the new modernised training programme, which the Christie Hospital had introduced at the time.

During his time at the Christie he obtained a wealth of experience in treating all tumours using the treatment modalities of radiotherapy and chemotherapy. During his time there he undertook some research including phase one research for a new chemotherapy treatment regime in colorectal cancer and in the management of central lines. He has had abstracts presented at the American Society of Clinical Oncology (ASCO) Meeting and her co-authored a chapter on the management of cancer of the stomach.

In the latter part of his training he particularly developed an interest in breast and gynaecological malignancies.

He was appointed Consultant at the Rosemere Cancer at Royal Preston Hospital in 2003 and was closely involved in the reconfiguration of the management of breast and gynaecological malignancies in East Lancashire where he is a visiting Consultant at the Royal Blackburn Hospital and the Burnley General Hospital. He is continuing to work to improve the standards of oncological care in those areas addressing issues that are reflected in the North West Cancer Plan and the Cancer Reform strategy such as developing the provision of local administration for chemotherapy, as close to the patients home as possible and access to high quality image guided radiotherapy.

He is currently Lead Clinician for breast cancer at the Rosemere Cancer Centre and is soon to take over the clinical directorship of the centre. He is also Chair of the Breast Cancer Network Site Specific Group for four years now. In addition to the standard clinical roles he has for a number of years run a conference for Breast Care Nurses in the North of England offering updates and education and work. He has worked closely with Dr Louise Foreman, a palliative care consultant colleague and has set up a National palliative Care Conference aimed at providing an Oncological update for palliative care consultants and specialist registrars (consultants in training).

In addition he leads Lancashire and South Cumbria Network in the Tri-network Meetings along with the Mersey and Greater Manchester groups and in 2008 organised and chaired the Tri-Network Meeting.

• Breast cancer
• Gynaecological cancer